On the 17th of May 2023, the company "Ananta Medicare" participated in an online symposium on the topic "General Medical Clinical Cases in the Practice of Physicians from Different Specialties"
On the 17th of May 2023, the company "Ananta Medicare" participated in an online symposium on the topic "General Medical Clinical Cases in the Practice of Physicians from Different Specialties," where experts discussed the most relevant issues of modern medicine.
The realities of modern life dictate their conditions. Improper nutrition and relatively new factors such as stress and insufficient physical activity due to remote work and learning not only contribute to the development of excessive weight and metabolic complications but also lead to changes in the gut microbiota. These changes result in an increase in pathogenic bacteria and the emergence of symptoms of dysbacteriosis, such as diarrhea, constipation, bloating, flatulence, heaviness, nausea and others. Conversely, the results of many studies demonstrate that dysbacteriosis can lead to systemic disorders in the body, indicated by changes in metabolic indicators.
Among the many presentations on various pathologies that our doctors encounter daily, Professor Tetiana Oleksandrivna Kryuchko delivered a presentation on the topic: "The Relevance of the Obesity Problem in Pediatric Practice." Her presentation highlighted the effectiveness and clinical necessity of using synbiotics to correct the condition of patients with dysbacteriosis symptoms and concurrent excess weight.
Professor Kryuchko T.O. shared the results of her own clinical study, in which children aged 10-17 years with manifestations of dysbacteriosis and accompanied by excess weight participated. The main group of children, along with comprehensive therapy, received the synbiotic complex "Santigen" in sachet form, which not only reduced the dyspeptic symptoms of dysbacteriosis but also, importantly, positively influenced the main indicators of the child's metabolic profile (lipid and carbohydrate metabolism). This additional advantage of the synbiotic complex "Santigen" provides an opportunity to further prevent the development and progression of obesity-related pathologies (primarily affecting the liver and cardiovascular system).
EVERYONE WITH DYSBACTERIOSIS NEEDS SANTIGEN, AND PATIENTS WITH DYSBACTERIOSIS AND EXCESS WEIGHT NEED SANTIGEN ONLY!